Willis Towers Watson PLC WTW
We take great care to ensure that the data presented and summarized in this overview for WILLIS TOWERS WATSON PLC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding WTW
View all-
Vanguard Group Inc Valley Forge, PA11.4MShares$3.63 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.96MShares$3.16 Billion0.06% of portfolio
-
Massachusetts Financial Services CO Boston, MA7.51MShares$2.39 Billion0.69% of portfolio
-
First Eagle Investment Management, LLC5.13MShares$1.63 Billion3.14% of portfolio
-
State Street Corp Boston, MA4.29MShares$1.36 Billion0.05% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.5MShares$1.11 Billion1.62% of portfolio
-
Geode Capital Management, LLC Boston, MA2.63MShares$835 Million0.06% of portfolio
-
Victory Capital Management Inc2MShares$636 Million0.6% of portfolio
-
Invesco Ltd. Atlanta, GA1.94MShares$617 Million0.11% of portfolio
-
Seth Klarman Baupost Group LLC | Boston, Ma1.78MShares$566 Million14.92% of portfolio
Latest Institutional Activity in WTW
Top Purchases
Top Sells
About WTW
Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. It operates through two segments, Health, Wealth and Career; and Risk and Broking. The company offers actuarial support, plan design, and administrative services for traditional pension and retirement savings plans; plan management consulting, broking, and administration services for health and group benefit programs; and benefits outsourcing services. It also provides advice, data, software, and products to address clients' total rewards and talent issues. In addition, the company offers risk advice, insurance brokerage, and consulting services in the areas of property and casualty, aerospace, construction, and marine. Further, it offers investment consulting and discretionary management services to insurance and reinsurance companies; insurance consulting and technology, risk and capital management, pricing and predictive modeling, financial and regulatory reporting, financial and capital modeling, merger and acquisition, outsourcing, and business management services; wholesale insurance broking services to retail and wholesale brokers; and underwriting and capital management, capital market, and advisory and brokerage services. Additionally, the company provides primary medical and ancillary benefit exchange, and outsourcing services to active employees and retirees in the group and individual markets, as well as delivers healthcare and reimbursement accounts, including health savings accounts, health reimbursement arrangements, flexible spending accounts, and other consumer-directed accounts. The company was formerly known as Willis Group Holdings Public Limited Company and changed its name to Willis Towers Watson Public Limited Company in January 2016. Willis Towers Watson Public Limited Company was founded in 1828 and is based in London, the United Kingdom.
Insider Transactions at WTW
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 18
2024
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
311
-0.4%
|
$97,032
$312.65 P/Share
|
Nov 18
2024
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Payment of exercise price or tax liability
|
Direct |
53
-0.04%
|
$16,536
$312.63 P/Share
|
Nov 18
2024
|
Joseph Stephen Kurpis PAO and Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
3
-0.34%
|
$936
$312.65 P/Share
|
Oct 17
2024
|
Alexis Faber Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3
-0.05%
|
$882
$294.53 P/Share
|
Oct 17
2024
|
Pamela Thomson Hall Head of International |
SELL
Payment of exercise price or tax liability
|
Direct |
3
-0.08%
|
$882
$294.53 P/Share
|
Oct 15
2024
|
Alexis Faber Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.1%
|
-
|
Oct 15
2024
|
Pamela Thomson Hall Head of International |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.12%
|
-
|
Oct 15
2024
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.01%
|
-
|
Oct 15
2024
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.01%
|
-
|
Oct 15
2024
|
Imran Ahmed Qureshi Head of North America |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.1%
|
-
|
Oct 15
2024
|
Joseph Stephen Kurpis PAO and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
0
|
-
|
Oct 15
2024
|
Kristy D Banas Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.07%
|
-
|
Oct 15
2024
|
Andrew Jay Krasner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.25%
|
-
|
Oct 15
2024
|
Anne Pullum Head of Europe |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.04%
|
-
|
Oct 15
2024
|
Carl Aaron Hess Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42
+0.05%
|
-
|
Oct 15
2024
|
Lucy Clarke President of Risk & Broking |
SELL
Payment of exercise price or tax liability
|
Direct |
2,424
-13.13%
|
$727,200
$300.58 P/Share
|
Oct 01
2024
|
Lucy Clarke President of Risk & Broking |
BUY
Grant, award, or other acquisition
|
Direct |
18,462
+38.23%
|
-
|
Oct 01
2024
|
Alexis Faber Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,020
-15.47%
|
$299,880
$294.53 P/Share
|
Oct 01
2024
|
Alexis Faber Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+1.49%
|
-
|
Oct 01
2024
|
Pamela Thomson Hall Head of International |
SELL
Payment of exercise price or tax liability
|
Direct |
848
-18.51%
|
$249,312
$294.53 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 70.9K shares |
---|---|
Exercise of in-the-money or at-the-money derivatives securities | 140 shares |
Exercise of conversion of derivative security | 401 shares |
Payment of exercise price or tax liability | 27.7K shares |
---|---|
Open market or private sale | 11.5K shares |